SCHEMBL25600985

SCHEMBL25600985

CCN(CC)CCN(C(=O)c1c(C)c(/C=C2\C(=O)Nc3ccc(F)cc32)n(C(C)(C)C)c1C)C(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 8/20 0.52
KDR P35968 12/20 0.51
PDGFRB P09619 7/20 0.51
PRKAA1 Q13131 7/20 0.51
PRKAA2 P54646 6/20 0.51
KIT P10721 4/20 0.51
CSF1R P07333 3/20 0.51
PLK4 O00444 2/20 0.51
DCLK1 O15075 2/20 0.51
PDPK1 O15530 2/20 0.51
DAPK3 O43293 2/20 0.51
ROCK2 O75116 2/20 0.51
RPS6KA5 O75582 2/20 0.51
RPS6KA4 O75676 2/20 0.51
MAP4K4 O95819 2/20 0.51
CHEK2 O96017 2/20 0.51
NTRK1 P04629 2/20 0.51
INSR P06213 2/20 0.51
LCK P06239 2/20 0.51
FYN P06241 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25603530 0.94 FLT3 (0.51) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL25600981 0.85 KDR (0.69) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL25600990 0.84 FLT3 (0.34) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL25600982 0.83 KDR (0.71) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL25603553 0.82 TRPA1 (0.35) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL25603510 0.79 KDR (0.67) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL28900853 0.76 KDR (0.56) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL25603549 0.75 FLT3 (0.34) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL28641704 0.75 KDR (0.55) FLT3KDRPDGFRBPRKAA1PRKAA2
SCHEMBL4566613 0.75 KDR (0.55) FLT3KDRPDGFRBPRKAA1PRKAA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230173079-A1 Conjugate Molecules DIVERSE BIOTECH, INC. (US) 2023-06-08 US disclosed
US-20230173079-A1 Conjugate Molecules DIVERSE BIOTECH, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230173079-A1 Conjugate Molecules CNR2, CNR1, MAG FLT3 1765/4885KDR 1602/4885PDGFRB 403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.